Medical Devices
Invisalign Gains Ground as Nashville Families Seek Discreet Orthodontic Options
Lucas Orthodontic Group expands Invisalign offerings for Nashville families, responding to growing patient demand for clear aligners as a discreet alternative to traditional braces.
Caggiano Orthodontics Expands vPro Accelerated Invisalign in Parsippany, NJ
Caggiano Orthodontics retains Diamond-tier Invisalign status and expands vPro accelerated treatment, offering up to 50% shorter treatment timelines for qualifying patients in Morris County.
Wearable Wristband Shows Promise in Detecting Cardiac Arrest, Study Finds
New research published in Circulation: Arrhythmia and Electrophysiology demonstrates that a smart wristband using photoplethysmography can detect cardiac arrest with 92% accuracy in a clinical setting, potentially enabling faster emergency response and improved survival for out-of-hospital cardiac arrest.
Oragenics Advances Phase IIa Concussion Trial, Eyes CNS Device Licensing
Oragenics provided a shareholder update on its Phase IIa trial of ONP-002 for concussion in Australia, plans for U.S. regulatory meetings, and a letter of intent to license a complementary CNS medical device.
Vycor Medical Posts Operating Profit in Q1 2026 as International Sales Drive Revenue Growth
Vycor Medical reported a 5% revenue increase to $458,540 for Q1 2026, achieving an operating profit of $45,808 compared to a loss last year, driven by international expansion and supported by new clinical studies on its ViewSite Brain Access System.
Stonegate Initiates Coverage on StimCell Energetics, Highlighting eBalance Device Potential
Stonegate Capital Partners has initiated coverage on StimCell Energetics Inc., focusing on its single-product eBalance platform and the upcoming home-use redesign, with early data suggesting promise but requiring further validation.
BioStem Technologies Posts Q1 2026 Revenue of $6.1M Amid Strategic Shift to Hospital Market
BioStem Technologies reported a net loss for Q1 2026 as it integrates BioTissue assets and pivots to hospital sales, with revenue declining from prior quarters but expecting sequential growth in H2 2026.
HeartBeam Advances Commercial Launch, Reports Improved Q1 2026 Results
HeartBeam reported first-quarter 2026 results highlighting initial commercial partnerships in key U.S. markets and an $11.5 million public offering, as it advances its FDA-cleared 3D ECG platform for heart attack detection and ambulatory monitoring.
Innovotech Secures $234,000 in NRC IRAP Funding for Advanced Antimicrobial Testing Services
Innovotech Inc. receives up to $234,000 CAD from NRC IRAP to develop antimicrobial testing services for medical devices, addressing evolving regulatory standards and rising client demand.
Sakowitz Smiles Explains Key Factors Behind Invisalign Recommendations for Teen Patients
Sakowitz Smiles Orthodontics outlines clinical and lifestyle criteria for recommending Invisalign over braces for teens, emphasizing case suitability, activity level, and compliance.
SS Innovations Reports Record Q1 Revenue, Driven by Robotic Surgery Growth
SS Innovations International reported a 117% increase in quarterly revenue to $11.1 million, driven by strong SSi Mantra installations and procedures, as the company pursues global expansion and FDA approval.
Viemed Healthcare's Revenue Mix Shift Drives Strong Cash Flow Growth, Stonegate Says
Stonegate Capital Partners updates coverage on Viemed Healthcare, highlighting improved growth quality from diversification into sleep, resupply, and maternal health, which boosted free cash flow.
Aclarion Adds First Private Practice Site in Los Angeles to CLARITY Trial
Aclarion announced the addition of Lanman Spinal Neurosurgery in Beverly Hills to its CLARITY trial, expanding enrollment beyond academic centers and highlighting growing interest in Nociscan for precise chronic low back pain diagnosis.
HeartBeam Launches Pilot Study for On-Demand 12-Lead ECG Patch Aimed at Ischemia Detection
HeartBeam Inc. has initiated a pilot study for its investigational on-demand 12-lead ECG patch in coronary artery disease patients, potentially expanding ambulatory cardiac monitoring into ischemia detection within a $2 billion market.
Oragenics Signs LOI to License CardioDialysis Technology for Brain Disorders
Oragenics Inc. has signed a letter of intent to license Sigyn Therapeutics' CardioDialysis blood purification technology, aiming to combine it with its intranasal neurosteroid candidate ONP-002 for a dual-modality approach to traumatic brain injury and neurodegenerative diseases.
HeartBeam Expands Concierge Cardiology Footprint with Atelier Health Agreement
HeartBeam Inc. has signed a commercial agreement with Beverly Hills-based Atelier Health, expanding its launch footprint into Southern California and completing its initial targeted markets for its cable-free 3D ECG technology.
Aclarion Expands Commercial Team Amid Triple-Digit Growth in Nociscan Utilization
Aclarion granted inducement stock options to its new Western U.S. Commercial Director as demand for its Nociscan platform surges, reflecting strong adoption of its AI-driven chronic low back pain diagnostic tool.
HeartBeam Targets Heart Disease with Advanced ECG Technology as Cardiovascular Deaths Surge
HeartBeam Inc. is developing next-generation ECG solutions to address the gap in early cardiac detection, as cardiovascular disease remains the leading cause of death in the U.S. with over 919,000 deaths in 2023.
SS Innovations Surpasses 10,500 Surgeries with SSi Mantra Robotic System, Signaling Growing Global Adoption
SS Innovations International announced that its SSi Mantra surgical robotic system has been used in over 10,500 procedures across 11 countries, highlighting the system's rapid adoption and potential to democratize robotic surgery.
Aclarion Expands Nociscan Use at Weill Cornell Medicine in New Trial on Disc Degeneration
Aclarion's second commercial agreement with Weill Cornell Medicine will deploy its Nociscan platform in a randomized controlled trial led by Dr. Roger Härtl, aiming to improve understanding and treatment of degenerative disc disease.
HeartBeam to Report Q1 Earnings, Update on Commercial Launch and AI Initiatives
HeartBeam Inc. will host a Q1 2026 earnings call to discuss financial results and provide updates on its limited commercial launch for arrhythmia assessment, extended-wear patch development, and AI programs, marking a pivotal moment for the company's cardiac care innovations.
NeuroOne Announces CFO Succession Plan as Ron McClurg Retires, Chris Volker Takes Over
NeuroOne Medical Technologies Corporation announced that CFO Ron McClurg will retire effective June 30, 2026, with current COO Chris Volker assuming the permanent CFO role, ensuring a smooth transition as the company advances its growth strategy.
Aclarion Reports 196% Surge in Nociscan Scans, Advances Reimbursement and Clinical Trials
Aclarion's Q1 2026 results show a 196% year-over-year increase in Nociscan scan volumes, driven by clinical adoption and payer coverage, with a strong cash position and upcoming CLARITY trial data expected in late 2026.
Regeneris Launches Flexlift™, an Office-Based Face and Neck Lift with Minimal Downtime
Regeneris introduces Flexlift™, a face and neck rejuvenation procedure developed by Dr. Edwin Ishoo that uses local anesthesia, reduces recovery time, and costs less than traditional facelifts.
VolitionRx Achieves Technical Milestone in Sepsis Detection with Finger-Prick Prototype
VolitionRx announced a prototype that can detect nucleosomes in capillary blood from sepsis patients, potentially enabling point-of-care testing and expanding access in regions with limited lab infrastructure.
OMRON Healthcare to Donate 3,000 Blood Pressure Monitors for May Measurement Month 2026
OMRON Healthcare supports May Measurement Month 2026 by donating 3,000 blood pressure monitors, including AFib-detecting models, to enhance global hypertension screening and awareness.
NeuroOne to Report Fiscal Q2 2026 Financial Results on May 12, Highlights Minimally Invasive Neurological Tech
NeuroOne Medical Technologies will announce its fiscal second quarter 2026 financial results on May 12, 2026, with a focus on its FDA-cleared electrode and ablation systems that aim to reduce hospitalizations and improve outcomes for neurological disorders.
Ventripoint's AI-Powered Cardiac Imaging System Submitted for Expedited Approval in China
Ventripoint Diagnostics announced that its VMS+ 4.0 system has been submitted for regulatory approval in China via an expedited 'green channel' pathway, potentially accelerating access to AI-driven cardiac diagnostics in a market with 330 million cardiovascular patients.
Aclarion Appoints Daniel Keefe as Commercial Director to Drive Western U.S. Expansion of Nociscan
Aclarion hires Daniel Keefe to lead Western U.S. commercial efforts, capitalizing on triple-digit growth in Nociscan utilization for chronic low back pain diagnosis.
Medartis Shareholders Overwhelmingly Approve Board Proposals, Elect Yang Xu at AGM 2026
Medartis shareholders approved all board proposals with over 90.9% support and elected Yang Xu to the board, signaling strong confidence in the company's governance and strategic direction.